6181 related articles for article (PubMed ID: 3308241)
1. Double blind randomized prospective trial of levamisole/placebo in stage I cutaneous malignant melanoma.
Loutfi A; Shakr A; Jerry M; Hanley J; Shibata HR
Clin Invest Med; 1987 Jul; 10(4):325-8. PubMed ID: 3308241
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.
Spitler LE; Sagebiel R
N Engl J Med; 1980 Nov; 303(20):1143-7. PubMed ID: 6999349
[TBL] [Abstract][Full Text] [Related]
3. Effect of levamisole as a surgical adjuvant therapy for malignant melanoma.
Gonzalez RL; Spitler LE; Sagebiel RW
Cancer Treat Rep; 1978 Nov; 62(11):1703-7. PubMed ID: 365324
[TBL] [Abstract][Full Text] [Related]
4. Levamisole in Crohn's disease: a randomized, double-blind, placebo-controlled clinical trial.
Sachar DB; Rubin KP; Gumaste V
Am J Gastroenterol; 1987 Jun; 82(6):536-9. PubMed ID: 3554991
[TBL] [Abstract][Full Text] [Related]
5. Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma.
Glaspy J; Atkins MB; Richards JM; Agarwala SS; O'Day S; Knight RD; Jungnelius JU; Bedikian AY
Cancer; 2009 Nov; 115(22):5228-36. PubMed ID: 19728370
[TBL] [Abstract][Full Text] [Related]
6. Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
Richtig E; Soyer HP; Posch M; Mossbacher U; Bauer P; Teban L; Svolba G; Wolf IH; Fritsch P; Zelger B; Volc-Platzer B; Gebhart W; Mischer P; Steiner A; Pachinger W; Hintner H; Gschnait F; Rappersberger K; Pilarski P; Pehamberger H;
J Clin Oncol; 2005 Dec; 23(34):8655-63. PubMed ID: 16260701
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma.
Veronesi U; Adamus J; Aubert C; Bajetta E; Beretta G; Bonadonna G; Bufalino R; Cascinelli N; Cocconi G; Durand J; De Marsillac J; Ikonopisov RL; Kiss B; Lejeune F; MacKie R; Madej G; Mulder H; Mechl Z; Milton GW; Morabito A; Peter H; Priario J; Paul E; Rumke P; Sertoli R; Tomin R
N Engl J Med; 1982 Oct; 307(15):913-6. PubMed ID: 7050717
[TBL] [Abstract][Full Text] [Related]
8. Double-blind trial of a polyvalent, shed-antigen, melanoma vaccine.
Bystryn JC; Zeleniuch-Jacquotte A; Oratz R; Shapiro RL; Harris MN; Roses DF
Clin Cancer Res; 2001 Jul; 7(7):1882-7. PubMed ID: 11448900
[TBL] [Abstract][Full Text] [Related]
9. Double-blind placebo-controlled evaluation of levamisole in chronic rheumatoid arthritis.
Franchimont P; Heynen G; Berghs H; Remans J; Vroninks P
Scand J Rheumatol; 1979; 8(1):43-8. PubMed ID: 373088
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized trial of 5-fluorouracil versus 5-fluorouracil plus levamisole in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial.
Bandealy MT; Gonin R; Loehrer PJ; Monaco F; Einhorn LH
Clin Cancer Res; 1998 Apr; 4(4):935-9. PubMed ID: 9563887
[TBL] [Abstract][Full Text] [Related]
11. Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group.
McDermott DF; Sosman JA; Gonzalez R; Hodi FS; Linette GP; Richards J; Jakub JW; Beeram M; Tarantolo S; Agarwala S; Frenette G; Puzanov I; Cranmer L; Lewis K; Kirkwood J; White JM; Xia C; Patel K; Hersh E
J Clin Oncol; 2008 May; 26(13):2178-85. PubMed ID: 18445842
[TBL] [Abstract][Full Text] [Related]
12. Levamisole treatment in ulcus cruris. A double-blind placebo-controlled study.
Morias J; Peremans W; Campaert H; Mertens RL
Arzneimittelforschung; 1979; 29(7):1050-2. PubMed ID: 387047
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report.
Wanebo HJ; Hilal EY; Pinsky CM; Strong EW; Mike V; Hirshaut Y; Oettgen HF
Cancer Treat Rep; 1978 Nov; 62(11):1663-9. PubMed ID: 365322
[TBL] [Abstract][Full Text] [Related]
14. Levamisole: a double blind immunological study.
Webster DJ; Whitehead RH; Richardson G; Hughes LE
Anticancer Res; 1982; 2(1-2):29-32. PubMed ID: 7051958
[TBL] [Abstract][Full Text] [Related]
15. Once weekly administration of levamisole in rheumatoid arthritis.
Fostiropoulos GA; Zissis NP; Marketos G
Clin Invest Med; 1982; 5(4):255-8. PubMed ID: 6218948
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymphadenectomy for staging patients with intermediate-level melanoma.
Smart KR; Cahoon BW; Dale PS
Am Surg; 2000 Mar; 66(3):280-3. PubMed ID: 10759200
[TBL] [Abstract][Full Text] [Related]
18. Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma.
Hauschild A; Agarwala SS; Trefzer U; Hogg D; Robert C; Hersey P; Eggermont A; Grabbe S; Gonzalez R; Gille J; Peschel C; Schadendorf D; Garbe C; O'Day S; Daud A; White JM; Xia C; Patel K; Kirkwood JM; Keilholz U
J Clin Oncol; 2009 Jun; 27(17):2823-30. PubMed ID: 19349552
[TBL] [Abstract][Full Text] [Related]
19. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
20. Levamisole therapy in atopic dermatitis: randomized double-blind evaluation.
White CR; Hanifin JM
Arch Dermatol; 1978 Sep; 114(9):1314-5. PubMed ID: 356738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
